BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25599820)

  • 1. Grading acute graft-versus-host disease: time to reconsider.
    Goyal RK; Goyal M; Sankaranarayan K
    Pediatr Transplant; 2015 May; 19(3):252-4. PubMed ID: 25599820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-versus-host disease following bone marrow transplantation: clinical feature and diagnosis.
    Kikuta A; Suzuki H
    Fukushima J Med Sci; 1993 Dec; 39(2):95-9. PubMed ID: 7927140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
    Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade.
    Rowlings PA; Przepiorka D; Klein JP; Gale RP; Passweg JR; Henslee-Downey PJ; Cahn JY; Calderwood S; Gratwohl A; Socié G; Abecasis MM; Sobocinski KA; Zhang MJ; Horowitz MM
    Br J Haematol; 1997 Jun; 97(4):855-64. PubMed ID: 9217189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular graft-versus-host disease: a review.
    Shikari H; Antin JH; Dana R
    Surv Ophthalmol; 2013; 58(3):233-51. PubMed ID: 23541042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of GVHD after blood transfusion.
    Sakuma H; Kikuta A; Suzuki H
    Fukushima J Med Sci; 1993 Dec; 39(2):113-6. PubMed ID: 7927134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute graft-versus-host disease of the kidney in allogeneic rat bone marrow transplantation.
    Higo S; Shimizu A; Masuda Y; Nagasaka S; Kajimoto Y; Kanzaki G; Fukui M; Nagahama K; Mii A; Kaneko T; Tsuruoka S
    PLoS One; 2014; 9(12):e115399. PubMed ID: 25541735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does oxypentifylline reduce the intensity of acute graft-versus-host disease following allogeneic bone marrow transplantation?
    Ghosh K; Hutchinson RM
    Haematologia (Budap); 1996; 28(1):45-51. PubMed ID: 9283904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation.
    Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Yamada S; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 1999 Nov; 24(9):1005-7. PubMed ID: 10556960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Graft vs host disease in a child undergoing allogeneic bone marrow transplantation].
    Nespoli L; Locatelli F
    Pediatr Med Chir; 1991; 13(1):17-23. PubMed ID: 2052451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease.
    Kohler S; Hendrickson MR; Chao NJ; Smoller BR
    Am J Surg Pathol; 1997 Sep; 21(9):988-96. PubMed ID: 9298874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
    Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
    Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
    Russell CA; Heilmann C; Madsen HO; Vindeløv LL
    Bone Marrow Transplant; 2001 May; 27(9):949-58. PubMed ID: 11436105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the dose of natural killer cells in the graft on severe acute graft-versus-host disease after unrelated bone marrow transplantation.
    Tanaka M; Kobayashi S; Numata A; Tachibana T; Takasaki H; Maruta A; Ishigatsubo Y; Kanamori H
    Leuk Res; 2012 Jun; 36(6):699-703. PubMed ID: 22172462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.
    Auletta JJ; Cooke KR
    Curr Opin Pediatr; 2009 Feb; 21(1):30-8. PubMed ID: 19242239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
    Theobald M; Nierle T; Bunjes D; Arnold R; Heimpel H
    N Engl J Med; 1992 Dec; 327(23):1613-7. PubMed ID: 1435898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
    Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
    Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.
    Nishida T; Hamaguchi M; Hirabayashi N; Haneda M; Terakura S; Atsuta Y; Imagama S; Kanie T; Murata M; Taji H; Suzuki R; Morishita Y; Kodera Y
    Bone Marrow Transplant; 2004 Jun; 33(11):1143-50. PubMed ID: 15077133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group.
    Appleton AL; Sviland L; Peiris JS; Taylor CE; Wilkes J; Green MA; Pearson AD; Kelly PJ; Malcolm AJ; Proctor SJ
    Bone Marrow Transplant; 1995 Dec; 16(6):777-82. PubMed ID: 8750269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.